Categories Meet the Expert Closing In on Cereblon: What’s Distinct About CELMoD Agents in Multiple Myeloma Wednesday, 18 Nov 2026, 3:20 p.m. - 3:40 p.m., Boston 1-2 Endorsed by: Bristol-Myers Squibb SA Speaker: Martina Bertschinger Thomas Lehmann